Genmab Ownership 2024 | Who Owns Genmab Now?
Institutional Ownership
73.19%
Insider Ownership
0.01%
Retail Ownership
26.80%
Institutional Holders
224.00
Genmab Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALLIANCEBERNSTEIN L.P. | 23.35% | 0.16% | 15,254,347 | -360,163 | -2.31% | 456,257,519 | Mar 31, 2024 |
| BLACKROCK INC. | 7.76% | 0.00% | 5,067,133 | 657,558 | 14.91% | 151,557,954 | Mar 31, 2024 |
| CAPITAL INTERNATIONAL INVESTORS | 6.69% | 0.03% | 4,373,277 | 315,355 | 7.77% | 130,804,719 | Mar 31, 2024 |
| HARDING LOEVNER LP | 5.04% | 0.61% | 3,294,728 | 4,833 | 0.15% | 98,542,150 | Mar 31, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.57% | 0.01% | 2,331,814 | -37,517 | -1.58% | 69,744,557 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 2.08% | 0.06% | 1,358,600 | -136,200 | -9.11% | 40,636,000 | Mar 31, 2024 |
| FIRST TRUST ADVISORS LP | 1.88% | 0.04% | 1,229,570 | -40,525 | -3.19% | 36,776,438 | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | 1.66% | 0.00% | 1,082,547 | 193,383 | 21.75% | 32,378,979,000 | Mar 31, 2024 |
| ENVESTNET ASSET MANAGEMENT INC | 1.56% | 0.01% | 1,022,130 | 96,212 | 10.39% | 30,571,900 | Mar 31, 2024 |
| MORGAN STANLEY | 1.49% | 0.00% | 974,036 | -115,061 | -10.56% | 29,133,468 | Mar 31, 2024 |
| MARSHALL WACE, LLP | 1.45% | 0.04% | 949,425 | 734,017 | 340.76% | 28,397,301 | Mar 31, 2024 |
| ROYAL BANK OF CANADA | 1.20% | 0.01% | 784,372 | 143,383 | 22.37% | 23,461,000 | Mar 31, 2024 |
| WELLS FARGO & COMPANY/MN | 1.14% | 0.01% | 746,477 | 189,345 | 33.99% | 22,327,127,000 | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 1.00% | 0.00% | 655,346 | 127,422 | 24.14% | 19,601,411 | Mar 31, 2024 |
| NORTHERN TRUST CORP | 0.85% | 0.00% | 554,228 | 15,198 | 2.82% | 16,576,960 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.73% | 0.01% | 473,929 | -38,352 | -7.49% | 14,175,216 | Mar 31, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.71% | 0.01% | 464,942 | 8,520 | 1.87% | 13,906,415 | Mar 31, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.62% | 0.04% | 406,680 | 271,230 | 200.24% | 12,163,799 | Mar 31, 2024 |
| FMR LLC | 0.57% | 0.00% | 374,407 | 106,902 | 39.96% | 11,198,521 | Mar 31, 2024 |
| HARDMAN JOHNSTON GLOBAL ADVISORS LLC | 0.40% | 0.27% | 262,489 | -220,168 | -45.62% | 7,851,046 | Mar 31, 2024 |
Genmab's largest institutional shareholder is ALLIANCEBERNSTEIN L.P., holding 23.35% of the company's total share outstanding, currently valued at $456.26M. The top 10 institutional shareholders own together 55.09% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| HARDING LOEVNER LP | 5.04% | 0.61% | 3,294,728 | 4,833 | 0.15% | 98,542,150 | Mar 31, 2024 |
| TORRAY INVESTMENT PARTNERS LLC | 0.17% | 0.48% | 107,934 | 733 | 0.68% | 3,228,306 | Mar 31, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.15% | 0.31% | 100,000 | 100,000 | 100.00% | 2,991,000 | Mar 31, 2024 |
| LEGACY WEALTH ASSET MANAGEMENT, LLC | 0.06% | 0.31% | 36,703 | 1,611 | 4.59% | 1,097,787 | Mar 31, 2024 |
| HARDMAN JOHNSTON GLOBAL ADVISORS LLC | 0.40% | 0.27% | 262,489 | -220,168 | -45.62% | 7,851,046 | Mar 31, 2024 |
| INGALLS & SNYDER LLC | 0.27% | 0.23% | 177,583 | 177,583 | 100.00% | 5,312,000 | Mar 31, 2024 |
| ALLIANCEBERNSTEIN L.P. | 23.35% | 0.16% | 15,254,347 | -360,163 | -2.31% | 456,257,519 | Mar 31, 2024 |
| THOMPSON DAVIS & CO., INC. | 0.01% | 0.14% | 6,750 | 6,750 | 100.00% | 201,893 | Mar 31, 2024 |
| GALLACHER CAPITAL MANAGEMENT LLC | 0.01% | 0.12% | 7,865 | 1,192 | 17.86% | 235,242 | Mar 31, 2024 |
| FOLKETRYGDFONDET | 0.26% | 0.11% | 170,385 | - | - | 5,096,215 | Mar 31, 2024 |
| MAROTTA ASSET MANAGEMENT | 0.02% | 0.09% | 15,042 | -523 | -3.36% | 449,906 | Mar 31, 2024 |
| XTX TOPCO LTD | 0.03% | 0.09% | 22,456 | 9,750 | 76.74% | 671,659 | Mar 31, 2024 |
| OPPENHEIMER ASSET MANAGEMENT INC. | 0.26% | 0.08% | 172,702 | -10,951 | -5.96% | 5,165,517 | Mar 31, 2024 |
| LVW ADVISORS, LLC | 0.02% | 0.07% | 14,787 | 161 | 1.10% | 442,280 | Mar 31, 2024 |
| BAROMETER CAPITAL MANAGEMENT INC. | 0.02% | 0.07% | 10,337 | 6,537 | 172.03% | 286,232 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 2.08% | 0.06% | 1,358,600 | -136,200 | -9.11% | 40,636,000 | Mar 31, 2024 |
| GROUPAMA ASSET MANAGMENT | 0.02% | 0.06% | 11,383 | 11,383 | 100.00% | 3,434,770 | Mar 31, 2024 |
| NEWEDGE WEALTH, LLC | 0.15% | 0.06% | 100,607 | -19,382 | -16.15% | 2,788,826 | Mar 31, 2024 |
| PARK PLACE CAPITAL CORP | 0.01% | 0.06% | 5,214 | 323 | 6.60% | 155,951 | Mar 31, 2024 |
| ONE WEALTH ADVISORS, LLC | 0.02% | 0.05% | 10,021 | 10,021 | 100.00% | 299,728 | Mar 31, 2024 |
The largest Genmab shareholder by % of total assets is HARDING LOEVNER LP. The company owns 3.29M shares of Genmab (GMAB), representing 0.61% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MARSHALL WACE, LLP | 1.45% | 0.04% | 949,425 | 734,017 | 340.76% | 28,397,301 | Mar 31, 2024 |
| BLACKROCK INC. | 7.76% | 0.00% | 5,067,133 | 657,558 | 14.91% | 151,557,954 | Mar 31, 2024 |
| CAPITAL INTERNATIONAL INVESTORS | 6.69% | 0.03% | 4,373,277 | 315,355 | 7.77% | 130,804,719 | Mar 31, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.62% | 0.04% | 406,680 | 271,230 | 200.24% | 12,163,799 | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.38% | 0.02% | 250,726 | 250,726 | 100.00% | 7,499,215 | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | 1.66% | 0.00% | 1,082,547 | 193,383 | 21.75% | 32,378,979,000 | Mar 31, 2024 |
| WELLS FARGO & COMPANY/MN | 1.14% | 0.01% | 746,477 | 189,345 | 33.99% | 22,327,127,000 | Mar 31, 2024 |
| INGALLS & SNYDER LLC | 0.27% | 0.23% | 177,583 | 177,583 | 100.00% | 5,312,000 | Mar 31, 2024 |
| ROYAL BANK OF CANADA | 1.20% | 0.01% | 784,372 | 143,383 | 22.37% | 23,461,000 | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 1.00% | 0.00% | 655,346 | 127,422 | 24.14% | 19,601,411 | Mar 31, 2024 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0.37% | 0.01% | 242,385 | 115,085 | 90.40% | 7,249,735 | Mar 31, 2024 |
| FMR LLC | 0.57% | 0.00% | 374,407 | 106,902 | 39.96% | 11,198,521 | Mar 31, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.15% | 0.31% | 100,000 | 100,000 | 100.00% | 2,991,000 | Mar 31, 2024 |
| ENVESTNET ASSET MANAGEMENT INC | 1.56% | 0.01% | 1,022,130 | 96,212 | 10.39% | 30,571,900 | Mar 31, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.13% | 0.00% | 85,200 | 85,200 | 100.00% | 2,548,332 | Mar 31, 2024 |
| BARCLAYS PLC | 0.09% | 0.00% | 61,005 | 61,005 | 100.00% | 1,825,000 | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | 0.09% | 0.00% | 57,300 | 57,300 | 100.00% | 1,713,843 | Mar 31, 2024 |
| CAMBER CAPITAL MANAGEMENT LP | 0.08% | 0.04% | 50,000 | 50,000 | 100.00% | 1,496,000 | Mar 31, 2024 |
| ABRDN PLC | 0.08% | 0.00% | 49,797 | 49,797 | 100.00% | 1,489,428 | Mar 31, 2024 |
| NATIXIS ADVISORS, L.P. | 0.36% | 0.02% | 235,974 | 48,176 | 25.65% | 7,058,000 | Mar 31, 2024 |
As of Mar 31 2024, Genmab's largest institutional buyer is MARSHALL WACE, LLP. The company purchased 734.02K stocks of GMAB, valued at $28.40M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STIFEL FINANCIAL CORP | 0.36% | 0.01% | 232,928 | -439,965 | -65.38% | 6,966,864 | Mar 31, 2024 |
| ALLIANCEBERNSTEIN L.P. | 23.35% | 0.16% | 15,254,347 | -360,163 | -2.31% | 456,257,519 | Mar 31, 2024 |
| HARDMAN JOHNSTON GLOBAL ADVISORS LLC | 0.40% | 0.27% | 262,489 | -220,168 | -45.62% | 7,851,046 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -189,491 | -100.00% | - | Mar 31, 2024 |
| ANTIPODES PARTNERS LTD | - | - | - | -185,698 | -100.00% | - | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 2.08% | 0.06% | 1,358,600 | -136,200 | -9.11% | 40,636,000 | Mar 31, 2024 |
| MORGAN STANLEY | 1.49% | 0.00% | 974,036 | -115,061 | -10.56% | 29,133,468 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.07% | 0.00% | 48,138 | -107,383 | -69.05% | 1,439,808 | Mar 31, 2024 |
| JPMORGAN CHASE & CO | 0.05% | 0.00% | 31,884 | -104,019 | -76.54% | 953,650 | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -101,100 | -100.00% | - | Mar 31, 2024 |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | - | - | - | -97,218 | -100.00% | - | Mar 31, 2024 |
| TREXQUANT INVESTMENT LP | 0.10% | 0.04% | 67,113 | -85,985 | -56.16% | 2,007,350 | Mar 31, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.20% | 0.02% | 132,852 | -79,594 | -37.47% | 3,973,603 | Mar 31, 2024 |
| BAMCO INC /NY/ | 0.11% | 0.01% | 72,231 | -66,714 | -48.01% | 2,160,429 | Mar 31, 2024 |
| WILLIAMS JONES WEALTH MANAGEMENT, LLC. | 0.14% | 0.03% | 89,435 | -60,702 | -40.43% | 2,675,001 | Mar 31, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | - | - | - | -59,003 | -100.00% | - | Mar 31, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.16% | 0.00% | 107,370 | -57,817 | -35.00% | 3,211,436,000 | Mar 31, 2024 |
| FIRST TRUST ADVISORS LP | 1.88% | 0.04% | 1,229,570 | -40,525 | -3.19% | 36,776,438 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.73% | 0.01% | 473,929 | -38,352 | -7.49% | 14,175,216 | Mar 31, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.57% | 0.01% | 2,331,814 | -37,517 | -1.58% | 69,744,557 | Mar 31, 2024 |
As of Mar 31 2024, Genmab's biggest institutional seller is STIFEL FINANCIAL CORP. The company sold -0.44M shares of GMAB, valued at $6.97M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | 0.38% | 0.02% | 250,726 | 250,726 | 100.00% | 7,499,215 | Mar 31, 2024 |
| INGALLS & SNYDER LLC | 0.27% | 0.23% | 177,583 | 177,583 | 100.00% | 5,312,000 | Mar 31, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.15% | 0.31% | 100,000 | 100,000 | 100.00% | 2,991,000 | Mar 31, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.13% | 0.00% | 85,200 | 85,200 | 100.00% | 2,548,332 | Mar 31, 2024 |
| BARCLAYS PLC | 0.09% | 0.00% | 61,005 | 61,005 | 100.00% | 1,825,000 | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | 0.09% | 0.00% | 57,300 | 57,300 | 100.00% | 1,713,843 | Mar 31, 2024 |
| CAMBER CAPITAL MANAGEMENT LP | 0.08% | 0.04% | 50,000 | 50,000 | 100.00% | 1,496,000 | Mar 31, 2024 |
| ABRDN PLC | 0.08% | 0.00% | 49,797 | 49,797 | 100.00% | 1,489,428 | Mar 31, 2024 |
| CAPITAL FUND MANAGEMENT S.A. | 0.06% | 0.00% | 39,551 | 39,551 | 100.00% | 1,182,970 | Mar 31, 2024 |
| SIMPLICITY WEALTH,LLC | 0.05% | 0.02% | 30,235 | 30,235 | 100.00% | 904,329 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.04% | 0.00% | 28,888 | 28,888 | 100.00% | 864,040 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.04% | 0.00% | 24,900 | 24,900 | 100.00% | 744,759 | Mar 31, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | 0.03% | 0.00% | 21,905 | 21,905 | 100.00% | 655,179 | Mar 31, 2024 |
| CLAL INSURANCE ENTERPRISES HOLDINGS LTD | 0.03% | 0.01% | 20,000 | 20,000 | 100.00% | 598,000 | Mar 31, 2024 |
| DYNASTY WEALTH MANAGEMENT, LLC | 0.02% | 0.01% | 13,472 | 13,472 | 100.00% | 402,948 | Mar 31, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.02% | 0.00% | 13,015 | 13,015 | 100.00% | 389,000 | Mar 31, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | 0.02% | 0.03% | 11,436 | 11,436 | 100.00% | 342,051 | Mar 31, 2024 |
| GROUPAMA ASSET MANAGMENT | 0.02% | 0.06% | 11,383 | 11,383 | 100.00% | 3,434,770 | Mar 31, 2024 |
| ONE WEALTH ADVISORS, LLC | 0.02% | 0.05% | 10,021 | 10,021 | 100.00% | 299,728 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.01% | - | 9,100 | 9,100 | 100.00% | 272,181 | Mar 31, 2024 |
| THOMPSON DAVIS & CO., INC. | 0.01% | 0.14% | 6,750 | 6,750 | 100.00% | 201,893 | Mar 31, 2024 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 0.00% | 0.00% | 1,453 | 1,453 | 100.00% | 43,459 | Mar 31, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | 0.00% | 0.00% | 1,225 | 1,225 | 100.00% | 36,639 | Mar 31, 2024 |
| RISE ADVISORS, LLC | 0.00% | 0.01% | 577 | 577 | 100.00% | 17,258 | Mar 31, 2024 |
| 0.00% | 0.00% | 558 | 558 | 100.00% | 16,271 | Mar 31, 2024 | |
| JANICZEK WEALTH MANAGEMENT, LLC | 0.00% | 0.00% | 370 | 370 | 100.00% | 11,067,000 | Mar 31, 2024 |
| BESSEMER GROUP INC | 0.00% | - | 185 | 185 | 100.00% | 6,000 | Mar 31, 2024 |
| MATHER GROUP, LLC. | 0.00% | 0.00% | 109 | 109 | 100.00% | 3,470,000 | Mar 31, 2024 |
| BELL INVESTMENT ADVISORS, INC | 0.00% | 0.00% | 80 | 80 | 100.00% | 2,393,000 | Mar 31, 2024 |
| CEDAR WEALTH MANAGEMENT, LLC | 0.00% | 0.00% | 64 | 64 | 100.00% | 1,914 | Mar 31, 2024 |
| NORTHWEST FINANCIAL ADVISORS | 0.00% | 0.00% | 41 | 41 | 100.00% | 1,226 | Mar 31, 2024 |
| 0.00% | - | 33 | 33 | 100.00% | 987 | Mar 31, 2024 | |
| ADVISORNET FINANCIAL, INC | - | 0.00% | 32 | 32 | 100.00% | 957,000 | Mar 31, 2024 |
| SALOMON & LUDWIN, LLC | - | 0.00% | 31 | 31 | 100.00% | 927 | Mar 31, 2024 |
| CORNERSTONE PLANNING GROUP LLC | - | 0.00% | 27 | 27 | 100.00% | 803 | Mar 31, 2024 |
| RICHARDSON FINANCIAL SERVICES INC. | - | 0.00% | 21 | 21 | 100.00% | 628 | Mar 31, 2024 |
| CONTINUUM ADVISORY, LLC | - | 0.00% | 18 | 18 | 100.00% | 519,000 | Mar 31, 2024 |
Genmab's largest new institutional shareholder by number of shares is TWO SIGMA INVESTMENTS, LP, purchased 250.73K shares, valued at $7.50M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ | - | - | - | -189,491 | -100.00% | - | Mar 31, 2024 |
| ANTIPODES PARTNERS LTD | - | - | - | -185,698 | -100.00% | - | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -101,100 | -100.00% | - | Mar 31, 2024 |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | - | - | - | -97,218 | -100.00% | - | Mar 31, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | - | - | - | -59,003 | -100.00% | - | Mar 31, 2024 |
| AIGEN INVESTMENT MANAGEMENT, LP | - | - | - | -35,889 | -100.00% | - | Mar 31, 2024 |
| ENGINEERS GATE MANAGER LP | - | - | - | -27,260 | -100.00% | - | Mar 31, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | - | - | - | -23,700 | -100.00% | - | Mar 31, 2024 |
| YORKTOWN MANAGEMENT & RESEARCH CO INC | - | - | - | -16,600 | -100.00% | - | Mar 31, 2024 |
| M&T BANK CORP | - | - | - | -15,432 | -100.00% | - | Mar 31, 2024 |
| CUSTOM INDEX SYSTEMS, LLC | - | - | - | -12,879 | -100.00% | - | Mar 31, 2024 |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | - | - | - | -12,513 | -100.00% | - | Mar 31, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | - | - | - | -11,944 | -100.00% | - | Mar 31, 2024 |
| MOLONEY SECURITIES ASSET MANAGEMENT, LLC | - | - | - | -10,604 | -100.00% | - | Mar 31, 2024 |
| GTS SECURITIES LLC | - | - | - | -9,337 | -100.00% | - | Mar 31, 2024 |
| FIRST TRUST DIRECT INDEXING L.P. | - | - | - | -9,045 | -100.00% | - | Mar 31, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -8,670 | -100.00% | - | Mar 31, 2024 |
| WEALTH ALLIANCE | - | - | - | -8,403 | -100.00% | - | Mar 31, 2024 |
| TD WATERHOUSE CANADA INC. | - | - | - | -7,169 | -100.00% | - | Mar 31, 2024 |
| HBK SORCE ADVISORY LLC | - | - | - | -7,073 | -100.00% | - | Mar 31, 2024 |
| SCIENTECH RESEARCH LLC | - | - | - | -6,864 | -100.00% | - | Mar 31, 2024 |
| KNIGHTS OF COLUMBUS ASSET ADVISORS LLC | - | - | - | -6,732 | -100.00% | - | Mar 31, 2024 |
| DORSEY & WHITNEY TRUST CO LLC | - | - | - | -6,576 | -100.00% | - | Mar 31, 2024 |
| ADVISORS PREFERRED, LLC | - | - | - | -2,563 | -100.00% | - | Mar 31, 2024 |
| ADVISORY SERVICES NETWORK, LLC | - | - | - | -1,118 | -100.00% | - | Mar 31, 2024 |
| TRADITION WEALTH MANAGEMENT, LLC | - | - | - | -962 | -100.00% | - | Mar 31, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -879 | -100.00% | - | Mar 31, 2024 |
| GLASSMAN WEALTH SERVICES | - | - | - | -304 | -100.00% | - | Mar 31, 2024 |
| TENNESSEE VALLEY ASSET MANAGEMENT PARTNERS | - | - | - | -275 | -100.00% | - | Mar 31, 2024 |
| BRUCE G. ALLEN INVESTMENTS, LLC | - | - | - | -93 | -100.00% | - | Mar 31, 2024 |
| PRINCETON GLOBAL ASSET MANAGEMENT LLC | - | - | - | -54 | -100.00% | - | Mar 31, 2024 |
| BOGART WEALTH, LLC | - | - | - | -50 | -100.00% | - | Mar 31, 2024 |
| FAIRFIELD, BUSH & CO. | - | - | - | -30 | -100.00% | - | Mar 31, 2024 |
| BOURGEON CAPITAL MANAGEMENT LLC | - | - | - | -23 | -100.00% | - | Mar 31, 2024 |
| CALDWELL SUTTER CAPITAL, INC. | - | - | - | -22 | -100.00% | - | Mar 31, 2024 |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | - | - | - | -22 | -100.00% | - | Mar 31, 2024 |
| GPS WEALTH STRATEGIES GROUP, LLC | - | - | - | -10 | -100.00% | - | Mar 31, 2024 |
| JONES FINANCIAL COMPANIES LLLP | - | - | - | -9 | -100.00% | - | Mar 31, 2024 |
Genmab's largest sold out institutional shareholder by shares sold is PRICE T ROWE ASSOCIATES INC /MD/, sold -0.19M shares, valued at -, as of undefined.
Genmab Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| SPARROW FUNDS | 1.58% | 5,635 | - | - | Feb 29, 2024 |
| AB CORE OPPORTUNITIES FUND, INC. | 0.98% | 48,425 | -37,289 | -43.50% | Feb 29, 2024 |
| DELAWARE GROUP EQUITY FUNDS IV | 0.42% | 447,643 | - | - | Dec 29, 2023 |
| PRUDENTIAL JENNISON MID-CAP GROWTH FUND, INC. | 0.34% | 694,664 | - | - | Feb 29, 2024 |
| AB LARGE CAP GROWTH FUND INC | 0.34% | 4,451,787 | 388,461 | 9.56% | Jan 31, 2024 |
| Tema ETF Trust | 0.27% | 12,127 | 181 | 1.52% | Feb 29, 2024 |
| ALGER FUNDS | 0.25% | 242,874 | - | - | Jan 31, 2024 |
| T. Rowe Price Tax-Efficient Funds, Inc. | 0.24% | 22,588 | - | - | Feb 29, 2024 |
| ALGER INSTITUTIONAL FUNDS | 0.19% | 49,006 | - | - | Jan 31, 2024 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.19% | 385,410 | - | - | Feb 29, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.12% | 1,264,417 | 175,792 | 16.15% | Dec 31, 2023 |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. | 0.12% | 64,577 | - | - | Dec 31, 2023 |
| LORD ABBETT RESEARCH FUND INC | 0.11% | 105,821 | - | - | Feb 29, 2024 |
| ALGER FUNDS II | 0.09% | 20,191 | - | - | Jan 31, 2024 |
| VANGUARD SPECIALIZED FUNDS | 0.06% | 3,150,246 | - | - | Jan 31, 2024 |
| Tekla Healthcare Opportunities Fund | 0.06% | 131,628 | - | - | Dec 31, 2023 |
| TEKLA LIFE SCIENCES INVESTORS | 0.05% | 29,963 | - | - | Dec 31, 2023 |
| BlackRock Health Sciences Trust | 0.05% | 19,943 | - | - | Dec 31, 2023 |
| BlackRock Health Sciences Trust II | 0.04% | 114,086 | - | - | Dec 31, 2023 |
| Starboard Investment Trust | 0.04% | 15,100 | - | - | Feb 29, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.04% | 43,052 | - | - | Dec 31, 2023 |
| Manager Directed Portfolios | 0.03% | 5,510 | - | - | Jan 31, 2024 |
| AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.03% | 147,067 | 1,469 | 1.01% | Mar 31, 2024 |
| IVY FUNDS | 0.02% | 1,976,731 | - | - | Dec 29, 2023 |
| ALGER PORTFOLIOS | 0.02% | 8,622 | - | - | Dec 31, 2023 |
| TOCQUEVILLE TRUST | 0.02% | 3,000 | - | - | Jan 31, 2024 |
| AZZAD FUNDS | 0.02% | 47,713 | - | - | Mar 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.02% | 76,565 | - | - | Jan 31, 2024 |
| STEWARD FUNDS, INC. | 0.01% | 35,528 | -4,511 | -11.27% | Jan 31, 2024 |
| BARON SELECT FUNDS | 0.01% | 138,945 | -10,000 | -6.71% | Dec 31, 2023 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.01% | 45,647 | - | - | Dec 31, 2023 |
| Trust for Advised Portfolios | 0.01% | 185,883 | - | - | Dec 31, 2023 |
| Listed Funds Trust | 0.01% | 4,069 | - | - | Feb 29, 2024 |
| AdvisorShares Trust | 0.01% | 25,185 | - | - | Dec 29, 2023 |
| Ivy Variable Insurance Portfolios | 0.01% | 163,574 | - | - | Dec 29, 2023 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 15,943 | 248 | 1.58% | Feb 29, 2024 |
| PAX WORLD FUNDS SERIES TRUST III | 0.00% | 1,348 | - | - | Dec 31, 2023 |
| TIAA-CREF LIFE FUNDS | 0.00% | 10,329 | - | - | Dec 31, 2023 |
| FIDELITY COVINGTON TRUST | 0.00% | 52,774 | 26,908 | 104.03% | Feb 29, 2024 |
| DOMINI INVESTMENT TRUST | 0.00% | 21,600 | - | - | Jan 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 14,700 | - | - | Dec 31, 2023 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 10,729 | - | - | Dec 31, 2023 |
| OHIO NATIONAL FUND INC | 0.00% | 52,820 | 18,693 | 54.77% | Dec 31, 2023 |
| GOLDMAN SACHS TRUST | 0.00% | 362,225 | - | - | Feb 29, 2024 |
| LORD ABBETT BOND DEBENTURE FUND INC | 0.00% | 501,788 | - | - | Dec 31, 2023 |
| TrimTabs ETF Trust | 0.00% | 1,224 | - | - | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 48,187 | - | - | Dec 29, 2023 |
| AMERICAN PENSION INVESTORS TRUST | 0.00% | 10,100 | -6,500 | -39.16% | Jan 31, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 270,739 | - | - | Jan 31, 2024 |
| LORD ABBETT SERIES FUND INC | 0.00% | 37,942 | - | - | Dec 31, 2023 |
| T. Rowe Price Equity Series, Inc. | 0.00% | 2,100 | - | - | Dec 31, 2023 |
| GLENMEDE FUND INC | 0.00% | 11,009 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 108,077 | 7,038 | 6.97% | Feb 29, 2024 |
| Franklin Custodian Funds | 0.00% | 500,000 | - | - | Dec 31, 2023 |
| SUNAMERICA SERIES TRUST | 0.00% | 328,471 | 23,353 | 7.65% | Jan 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 8,040 | - | - | Dec 29, 2023 |
| Listed Funds Trust | 0.00% | 388 | - | - | Feb 29, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 2,656 | - | - | Dec 29, 2023 |
| T. Rowe Price International Funds, Inc. | 0.00% | 62,633 | - | - | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND VI | 0.00% | 2,189 | - | - | Dec 31, 2023 |
| Voya PARTNERS INC | 0.00% | 33,400 | - | - | Dec 31, 2023 |
| T. Rowe Price Exchange-Traded Funds, Inc. | 0.00% | 2,393 | - | - | Feb 29, 2024 |
| CALAMOS INVESTMENT TRUST/IL | 0.00% | 38,800 | - | - | Jan 31, 2024 |
| Advisors Preferred Trust | 0.00% | 2,563 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 21,490 | - | - | Feb 29, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND II | 0.00% | 1,983 | - | - | Dec 31, 2023 |
| TRANSAMERICA SERIES TRUST | 0.00% | 270,516 | - | - | Dec 31, 2023 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 337,039 | - | - | Dec 31, 2023 |
| ETF Series Solutions | 0.00% | 4,341 | 693 | 19.00% | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 3,584,944 | - | - | Feb 29, 2024 |
| BlackRock ETF Trust | 0.00% | 189 | 7 | 3.85% | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 81,292 | - | - | Jan 31, 2024 |
| VALIC Co I | 0.00% | 40,940 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 27,016 | 1,375 | 5.36% | Feb 29, 2024 |
| SHP ETF Trust | 0.00% | 440 | - | - | Feb 29, 2024 |
| Franklin Global Trust | 0.00% | 40,000 | - | - | Jan 31, 2024 |
| Pacer Funds Trust | 0.00% | 5,810 | - | - | Jan 31, 2024 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 33,672 | 19,817 | 143.03% | Feb 29, 2024 |
| Guardian Variable Products Trust | 0.00% | 1,782 | - | - | Dec 31, 2023 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 189,369 | 51,377 | 37.23% | Dec 31, 2023 |
| THRIVENT SERIES FUND INC | 0.00% | 8,464 | - | - | Dec 29, 2023 |
| BAIRD FUNDS INC | 0.00% | 80,685 | - | - | Dec 31, 2023 |
| Goldman Sachs ETF Trust | 0.00% | 6,690 | -4,937 | -42.46% | Feb 29, 2024 |
| GPS Funds I | 0.00% | 322 | - | - | Dec 31, 2023 |
| SEASONS SERIES TRUST | 0.00% | 1,516 | - | - | Dec 31, 2023 |
| RBB FUND, INC. | 0.00% | 5,334 | - | - | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 3,309 | - | - | Feb 29, 2024 |
| BLACKROCK FUNDS | 0.00% | 289,405 | - | - | Feb 29, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 12,784 | 5,201 | 68.59% | Dec 31, 2023 |
| LORD ABBETT TRUST I | 0.00% | 823 | - | - | Jan 31, 2024 |
| RBB FUND, INC. | 0.00% | 2,330 | - | - | Feb 29, 2024 |
| Franklin Alternative Strategies Funds | 0.00% | 13,614 | - | - | Feb 29, 2024 |
| Bridge Builder Trust | 0.00% | 129,533 | - | - | Dec 31, 2023 |
| ADVANCED SERIES TRUST | 0.00% | 77,143 | - | - | Dec 29, 2023 |
| PAX WORLD FUNDS SERIES TRUST I | 0.00% | 271 | - | - | Dec 31, 2023 |
| PROSHARES TRUST | 0.00% | 3,133 | 458 | 17.12% | Feb 29, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 12,879 | 3,863 | 42.85% | Dec 31, 2023 |
| Fidelity Rutland Square Trust II | 0.00% | 13,417 | - | - | Feb 29, 2024 |
| AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS) | 0.00% | 21,685 | - | - | Dec 31, 2023 |
| Brighthouse Funds Trust II | 0.00% | 8,623 | - | - | Dec 31, 2023 |
Genmab's largest mutual fund holder by % of total assets is "SPARROW FUNDS", owning 5.63K shares, compromising 1.58% of its total assets.
Genmab Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 224 | 1.82% |
| 31 Dec, 23 | 220 | -4.35% |
| 30 Sep, 23 | 230 | 11.11% |
| 30 Jun, 23 | 207 | -1.43% |
| 31 Mar, 23 | 210 | -9.48% |
| 31 Dec, 22 | 232 | 22.11% |
| 30 Sep, 22 | 190 | 9.20% |
| 30 Jun, 22 | 174 | -13.00% |
| 31 Mar, 22 | 200 | -3.38% |
| 31 Dec, 21 | 207 | -0.96% |
| 30 Sep, 21 | 209 | -1.42% |
| 30 Jun, 21 | 212 | 2.91% |
| 31 Mar, 21 | 206 | -7.21% |
| 31 Dec, 20 | 222 | 12.12% |
| 30 Sep, 20 | 198 | 13.79% |
| 30 Jun, 20 | 174 | 25.18% |
| 31 Mar, 20 | 139 | 9.45% |
| 31 Dec, 19 | 127 | 32.29% |
| 30 Sep, 19 | 96 | 1271.43% |
| 30 Jun, 19 | 7 | -12.50% |
| 31 Mar, 19 | 8 | 33.33% |
| 31 Dec, 18 | 6 | - |
| 30 Sep, 18 | 6 | - |
| 30 Jun, 18 | 6 | 20.00% |
| 31 Mar, 18 | 5 | 25.00% |
| 31 Dec, 17 | 4 | -20.00% |
| 30 Sep, 17 | 5 | 25.00% |
| 30 Jun, 17 | 4 | 33.33% |
| 31 Mar, 17 | 3 | 50.00% |
| 31 Dec, 16 | 2 | 100.00% |
| 30 Sep, 16 | 1 | - |
| 30 Jun, 16 | 1 | - |
| 30 Sep, 14 | 1 | - |
| 30 Jun, 14 | 1 | - |
| 31 Mar, 14 | 1 | - |
| 31 Mar, 10 | 1 | - |
As of 31 Mar 24, 224 institutions are holding Genmab's shares, representing an increase of 1.82% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 47,815,064 | 2.62% |
| 31 Dec, 23 | 46,595,960 | -1.72% |
| 30 Sep, 23 | 47,412,397 | 13.85% |
| 30 Jun, 23 | 41,644,018 | -4.19% |
| 31 Mar, 23 | 43,464,796 | -4.94% |
| 31 Dec, 22 | 45,723,241 | 3.00% |
| 30 Sep, 22 | 44,389,885 | 24.98% |
| 30 Jun, 22 | 35,518,616 | -9.01% |
| 31 Mar, 22 | 39,037,800 | -1.75% |
| 31 Dec, 21 | 39,731,386 | -6.93% |
| 30 Sep, 21 | 42,689,395 | -7.50% |
| 30 Jun, 21 | 46,152,695 | 10.53% |
| 31 Mar, 21 | 41,755,039 | -0.94% |
| 31 Dec, 20 | 42,152,297 | 3.17% |
| 30 Sep, 20 | 40,856,630 | 7.82% |
| 30 Jun, 20 | 37,892,650 | 32.92% |
| 31 Mar, 20 | 28,507,799 | 19.87% |
| 31 Dec, 19 | 23,781,888 | -6.00% |
| 30 Sep, 19 | 25,298,831 | 2211.77% |
| 30 Jun, 19 | 1,094,347 | 4.58% |
| 31 Mar, 19 | 1,046,385 | 205.21% |
| 31 Dec, 18 | 342,843 | 8.58% |
| 30 Sep, 18 | 315,759 | -27.87% |
| 30 Jun, 18 | 437,761 | 415.98% |
| 31 Mar, 18 | 84,840 | 88.20% |
| 31 Dec, 17 | 45,079 | 4.41% |
| 30 Sep, 17 | 43,176 | 19.09% |
| 30 Jun, 17 | 36,255 | 50.09% |
| 31 Mar, 17 | 24,155 | 31.73% |
| 31 Dec, 16 | 18,337 | 459.40% |
| 30 Sep, 16 | 3,278 | -14.46% |
| 30 Jun, 16 | 3,832 | - |
| 30 Sep, 14 | 445 | 256.00% |
| 30 Jun, 14 | 125 | 7.76% |
| 31 Mar, 14 | 116 | - |
| 31 Mar, 10 | 35 | - |
Genmab (GMAB) has 47.82M shares outstanding as of 31 Mar 24, up 2.62% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 73.19% | 143.77% |
| 31 Dec, 23 | 7.13% | 13.51% |
| 30 Sep, 23 | 7.27% | 18.25% |
| 30 Jun, 23 | 6.31% | 14.55% |
| 31 Mar, 23 | 6.59% | 13.47% |
| 31 Dec, 22 | 6.99% | 15.12% |
| 30 Sep, 22 | 6.80% | 23.12% |
| 30 Jun, 22 | 5.42% | 15.26% |
| 31 Mar, 22 | 5.96% | 16.15% |
| 31 Dec, 21 | 6.08% | 14.26% |
| 30 Sep, 21 | 6.53% | 13.10% |
| 30 Jun, 21 | 7.06% | 17.31% |
| 31 Mar, 21 | 6.39% | 15.27% |
| 31 Dec, 20 | 6.47% | 16.46% |
| 30 Sep, 20 | 6.27% | 18.50% |
| 30 Jun, 20 | 5.82% | 30.38% |
| 31 Mar, 20 | 4.38% | 31.78% |
| 31 Dec, 19 | 3.71% | 23.81% |
| 30 Sep, 19 | 3.95% | 12472.51% |
| 30 Jun, 19 | 0.18% | 608.42% |
| 31 Mar, 19 | 0.17% | 5456.79% |
| 31 Dec, 18 | 0.06% | 2111.46% |
| 30 Sep, 18 | 0.05% | 1004.05% |
| 30 Jun, 18 | 0.07% | 37086.33% |
| 31 Mar, 18 | 0.01% | 27384.51% |
| 31 Dec, 17 | 0.01% | 15354.41% |
| 30 Sep, 17 | 0.01% | 19131.67% |
| 30 Jun, 17 | 0.01% | 35875.61% |
| 31 Mar, 17 | 0.00% | 42748.39% |
| 31 Dec, 16 | 0.00% | 1118800.00% |
| 30 Sep, 16 | 0.00% | 141783.33% |
| 30 Jun, 16 | 0.00% | - |
| 30 Sep, 14 | 0.00% | - |
| 30 Jun, 14 | - | - |
| 31 Mar, 14 | - | - |
| 31 Mar, 10 | - | - |
As of 31 Mar 24, Genmab is held by 73.19% institutional shareholders, representing a 143.77% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 126 | 32.63% |
| 31 Dec, 23 | 95 | -30.15% |
| 30 Sep, 23 | 136 | 38.78% |
| 30 Jun, 23 | 98 | - |
| 31 Mar, 23 | 98 | -27.94% |
| 31 Dec, 22 | 136 | 21.43% |
| 30 Sep, 22 | 112 | 55.56% |
| 30 Jun, 22 | 72 | -24.21% |
| 31 Mar, 22 | 95 | -4.04% |
| 31 Dec, 21 | 99 | -19.51% |
| 30 Sep, 21 | 123 | -0.81% |
| 30 Jun, 21 | 124 | 12.73% |
| 31 Mar, 21 | 110 | -19.71% |
| 31 Dec, 20 | 137 | 11.38% |
| 30 Sep, 20 | 123 | 6.96% |
| 30 Jun, 20 | 115 | 43.75% |
| 31 Mar, 20 | 80 | -6.98% |
| 31 Dec, 19 | 86 | -8.51% |
| 30 Sep, 19 | 94 | 2250.00% |
| 30 Jun, 19 | 4 | -42.86% |
| 31 Mar, 19 | 7 | 75.00% |
| 31 Dec, 18 | 4 | 33.33% |
| 30 Sep, 18 | 3 | -50.00% |
| 30 Jun, 18 | 6 | 50.00% |
| 31 Mar, 18 | 4 | 100.00% |
| 31 Dec, 17 | 2 | -33.33% |
| 30 Sep, 17 | 3 | 50.00% |
| 30 Jun, 17 | 2 | - |
| 31 Mar, 17 | 2 | - |
| 31 Dec, 16 | 2 | - |
| 30 Sep, 16 | - | -100.00% |
| 30 Jun, 16 | 1 | - |
| 30 Sep, 14 | 1 | - |
| 30 Jun, 14 | 1 | - |
| 31 Mar, 14 | 1 | - |
| 31 Mar, 10 | 1 | - |
126 institutional shareholders have increased their position in GMAB stock as of 31 Mar 24 compared to 95 in the previous quarter (a 32.63% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 70 | -29.29% |
| 31 Dec, 23 | 99 | 80.00% |
| 30 Sep, 23 | 55 | -29.49% |
| 30 Jun, 23 | 78 | -12.36% |
| 31 Mar, 23 | 89 | 12.66% |
| 31 Dec, 22 | 79 | 33.90% |
| 30 Sep, 22 | 59 | -25.32% |
| 30 Jun, 22 | 79 | -2.47% |
| 31 Mar, 22 | 81 | -1.22% |
| 31 Dec, 21 | 82 | 49.09% |
| 30 Sep, 21 | 55 | - |
| 30 Jun, 21 | 55 | -20.29% |
| 31 Mar, 21 | 69 | 18.97% |
| 31 Dec, 20 | 58 | 11.54% |
| 30 Sep, 20 | 52 | 23.81% |
| 30 Jun, 20 | 42 | -4.55% |
| 31 Mar, 20 | 44 | 62.96% |
| 31 Dec, 19 | 27 | - |
| 30 Sep, 19 | - | -100.00% |
| 30 Jun, 19 | 2 | - |
| 31 Mar, 19 | - | -100.00% |
| 31 Dec, 18 | 1 | -66.67% |
| 30 Sep, 18 | 3 | - |
| 30 Jun, 18 | - | -100.00% |
| 31 Mar, 18 | 1 | -50.00% |
| 31 Dec, 17 | 2 | 100.00% |
| 30 Sep, 17 | 1 | - |
| 30 Jun, 17 | 1 | - |
| 31 Mar, 17 | 1 | - |
| 31 Dec, 16 | - | -100.00% |
| 30 Sep, 16 | 1 | - |
| 30 Jun, 16 | - | - |
| 30 Sep, 14 | - | - |
| 30 Jun, 14 | - | - |
| 31 Mar, 14 | - | - |
| 31 Mar, 10 | - | - |
70 institutional shareholders have reduced their position in GMAB stock as of 31 Mar 24 compared to 99 in the previous quarter (a -29.29% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 224 | 1.82% | 47,815,064 | 2.62% | 73.19% | 143.77% | 126 | 32.63% | 70 | -29.29% |
| 31 Dec, 23 | 220 | -4.35% | 46,595,960 | -1.72% | 7.13% | 13.51% | 95 | -30.15% | 99 | 80.00% |
| 30 Sep, 23 | 230 | 11.11% | 47,412,397 | 13.85% | 7.27% | 18.25% | 136 | 38.78% | 55 | -29.49% |
| 30 Jun, 23 | 207 | -1.43% | 41,644,018 | -4.19% | 6.31% | 14.55% | 98 | - | 78 | -12.36% |
| 31 Mar, 23 | 210 | -9.48% | 43,464,796 | -4.94% | 6.59% | 13.47% | 98 | -27.94% | 89 | 12.66% |
| 31 Dec, 22 | 232 | 22.11% | 45,723,241 | 3.00% | 6.99% | 15.12% | 136 | 21.43% | 79 | 33.90% |
| 30 Sep, 22 | 190 | 9.20% | 44,389,885 | 24.98% | 6.80% | 23.12% | 112 | 55.56% | 59 | -25.32% |
| 30 Jun, 22 | 174 | -13.00% | 35,518,616 | -9.01% | 5.42% | 15.26% | 72 | -24.21% | 79 | -2.47% |
| 31 Mar, 22 | 200 | -3.38% | 39,037,800 | -1.75% | 5.96% | 16.15% | 95 | -4.04% | 81 | -1.22% |
| 31 Dec, 21 | 207 | -0.96% | 39,731,386 | -6.93% | 6.08% | 14.26% | 99 | -19.51% | 82 | 49.09% |
| 30 Sep, 21 | 209 | -1.42% | 42,689,395 | -7.50% | 6.53% | 13.10% | 123 | -0.81% | 55 | - |
| 30 Jun, 21 | 212 | 2.91% | 46,152,695 | 10.53% | 7.06% | 17.31% | 124 | 12.73% | 55 | -20.29% |
| 31 Mar, 21 | 206 | -7.21% | 41,755,039 | -0.94% | 6.39% | 15.27% | 110 | -19.71% | 69 | 18.97% |
| 31 Dec, 20 | 222 | 12.12% | 42,152,297 | 3.17% | 6.47% | 16.46% | 137 | 11.38% | 58 | 11.54% |
| 30 Sep, 20 | 198 | 13.79% | 40,856,630 | 7.82% | 6.27% | 18.50% | 123 | 6.96% | 52 | 23.81% |
| 30 Jun, 20 | 174 | 25.18% | 37,892,650 | 32.92% | 5.82% | 30.38% | 115 | 43.75% | 42 | -4.55% |
| 31 Mar, 20 | 139 | 9.45% | 28,507,799 | 19.87% | 4.38% | 31.78% | 80 | -6.98% | 44 | 62.96% |
| 31 Dec, 19 | 127 | 32.29% | 23,781,888 | -6.00% | 3.71% | 23.81% | 86 | -8.51% | 27 | - |
| 30 Sep, 19 | 96 | 1271.43% | 25,298,831 | 2211.77% | 3.95% | 12472.51% | 94 | 2250.00% | - | -100.00% |
| 30 Jun, 19 | 7 | -12.50% | 1,094,347 | 4.58% | 0.18% | 608.42% | 4 | -42.86% | 2 | - |
| 31 Mar, 19 | 8 | 33.33% | 1,046,385 | 205.21% | 0.17% | 5456.79% | 7 | 75.00% | - | -100.00% |
| 31 Dec, 18 | 6 | - | 342,843 | 8.58% | 0.06% | 2111.46% | 4 | 33.33% | 1 | -66.67% |
| 30 Sep, 18 | 6 | - | 315,759 | -27.87% | 0.05% | 1004.05% | 3 | -50.00% | 3 | - |
| 30 Jun, 18 | 6 | 20.00% | 437,761 | 415.98% | 0.07% | 37086.33% | 6 | 50.00% | - | -100.00% |
| 31 Mar, 18 | 5 | 25.00% | 84,840 | 88.20% | 0.01% | 27384.51% | 4 | 100.00% | 1 | -50.00% |
| 31 Dec, 17 | 4 | -20.00% | 45,079 | 4.41% | 0.01% | 15354.41% | 2 | -33.33% | 2 | 100.00% |
| 30 Sep, 17 | 5 | 25.00% | 43,176 | 19.09% | 0.01% | 19131.67% | 3 | 50.00% | 1 | - |
| 30 Jun, 17 | 4 | 33.33% | 36,255 | 50.09% | 0.01% | 35875.61% | 2 | - | 1 | - |
| 31 Mar, 17 | 3 | 50.00% | 24,155 | 31.73% | 0.00% | 42748.39% | 2 | - | 1 | - |
| 31 Dec, 16 | 2 | 100.00% | 18,337 | 459.40% | 0.00% | 1118800.00% | 2 | - | - | -100.00% |
| 30 Sep, 16 | 1 | - | 3,278 | -14.46% | 0.00% | 141783.33% | - | -100.00% | 1 | - |
| 30 Jun, 16 | 1 | - | 3,832 | - | 0.00% | - | 1 | - | - | - |
| 30 Sep, 14 | 1 | - | 445 | 256.00% | 0.00% | - | 1 | - | - | - |
| 30 Jun, 14 | 1 | - | 125 | 7.76% | - | - | 1 | - | - | - |
| 31 Mar, 14 | 1 | - | 116 | - | - | - | 1 | - | - | - |
| 31 Mar, 10 | 1 | - | 35 | - | - | - | 1 | - | - | - |
Genmab Peer Ownership
| Ticker | Company |
|---|---|
| TERN | Terns Pharmaceuticals, Inc. |
| AKRO | Akero Therapeutics, Inc. |
| TVTX | Travere Therapeutics, Inc. |
| BGNE | BeiGene, Ltd. |
| PCVX | Vaxcyte, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
| LEGN | Legend Biotech Corporation |
| BPMC | Blueprint Medicines Corporation |
| ALEC | Alector, Inc. |
| APLS | Apellis Pharmaceuticals, Inc. |
| CYTK | Cytokinetics, Incorporated |
| ASND | Ascendis Pharma A/S |
GMAB Ownership FAQ
Who Owns Genmab?
Genmab is owned by institutional shareholders (73.19%), insiders (0.01%), and public (26.80%). The largest institutional shareholder of Genmab is ALLIANCEBERNSTEIN L.P. (23.35% of total shares) and the top mutual fund owner is SPARROW FUNDS (1.58% of total shares).
Who are the major institutional shareholders of Genmab?
Genmab's major institutional shareholders are ALLIANCEBERNSTEIN L.P., BLACKROCK INC., CAPITAL INTERNATIONAL INVESTORS, HARDING LOEVNER LP, and WELLINGTON MANAGEMENT GROUP LLP. The top five shareholders own together 46.41% of the company's share outstanding.
How many Genmab shareholders are there?
As of Mar 2024, there are 224 institutional shareholders of Genmab.
What percentage of Genmab is owned by ALLIANCEBERNSTEIN L.P?
ALLIANCEBERNSTEIN L.P owns 15.25M shares of Genmab, representing 23.35% of the company's total shares outstanding, valued at $456.26M (as of Mar 2024).
What percentage of Genmab is owned by BLACKROCK INC?
As of Mar 2024, BLACKROCK INC holds 5.07M shares of Genmab (GMAB), compromising 7.76% of the company, valued at $151.56M.
What percentage of Genmab is owned by CAPITAL INTERNATIONAL INVESTORS?
CAPITAL INTERNATIONAL INVESTORS is the third largest holder of Genmab. The company owns 4.37M of the company's shares outstanding (worth $130.8M).